A U.S. District Court judge has again rejected GlaxoSmithKline’s arguments that its corporate citizenship is different completely from several plaintiffs in drug products liability cases because the drugmaker converted to a limited liability company based in Delaware.

U.S. District Court Judge Timothy J. Savage of the Eastern District of Pennsylvania ruled early this spring that GSK cannot claim Delaware citizenship for purposes of federal diversity jurisdiction because GSK’s true “nerve center” is in Philadelphia.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]